Literature DB >> 21965789

Association of caveolin-1 genotypes with nasopharyngeal carcinoma susceptibility in Taiwan.

Yung-An Tsou1, Chia-Wen Tsai, Ming-Hsui Tsai, Wen-Shin Chang, Fang-Jing Li, Yen-Fang Liu, Chang-Fang Chiu, Cheng-Chieh Lin, Da-Tian Bau.   

Abstract

BACKGROUND: Caveolin-1 (Cav-1), which has been proposed as a candidate tumor suppressor, plays a regulatory role in several signaling pathways. High expression of Cav-1 in nasopharyngeal carcinoma (NPC) may enhance tumor cell migration and correlate with poor prognosis of the patients, while the genetic alterations of Cav-1 during nasopharyngeal carcinogenesis are still largely unknown. The aim of this study was to evaluate the association between NPC susceptibility and Cav-1 genotypes. PATIENTS AND METHODS: One hundred and seventy six patients with NPC and 176 age- and gender-matched healthy controls recruited in Taiwan were genotyped and analyzed by PCR-restriction fragment length polymorphism.
RESULTS: There were significant differences between the NPC and control groups in the distributions of the genotypic (p=0.0019) and allelic frequencies (p=2.5 10(-4)) in the Cav-1 T29107A (rs7804372) polymorphism.
CONCLUSION: In this first report of Cav-1 involvement in NPC the A allele of Cav-1 T29107A is found to be protective against the development of NPC and may be a novel useful genomic marker for early screening and prediction of NPC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965789

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

Review 1.  Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.

Authors:  Allan Hildesheim; Cheng-Ping Wang
Journal:  Semin Cancer Biol       Date:  2012-01-25       Impact factor: 15.707

2.  Interaction among Caveolin-1 genotypes (rs3807987/rs7804372), H. pylori infection, and risk of gastric cancer in a Chinese population.

Authors:  Ye Zhang; Xue-jun Hu; Lu-lu Zhang; Li-ping Sun; Yuan Yuan; Xiu-juan Qu; Yun-peng Liu
Journal:  Tumour Biol       Date:  2013-09-25

3.  Quantitative assessment of caveolin-1 G14713A polymorphism and cancer susceptibility in the Asian population.

Authors:  Jianjun Tang; Gang Wang; Qiang Li; Rongfeng Song
Journal:  Onco Targets Ther       Date:  2016-03-10       Impact factor: 4.147

4.  Interleukin-18 promoter genotype is associated with the risk of nasopharyngeal carcinoma in Taiwan.

Authors:  Chung-Yu Huang; Wen-Shin Chang; Chia-Wen Tsai; Te-Chun Hsia; Te-Chun Shen; Da-Tian Bau; Hao-Ai Shui
Journal:  Cancer Manag Res       Date:  2018-10-31       Impact factor: 3.989

5.  Caveolin-1 Variant Is Associated With the Metabolic Syndrome in Kuwaiti Children.

Authors:  Rasheeba Nizam; Ebaa Al-Ozairi; Jo Max Goodson; Motesam Melhem; Lena Davidsson; Hessa Alkhandari; Ashraf Al Madhoun; Sara Shamsah; Malak Qaddoumi; Ghazi Alghanim; Nouf Alhasawi; Mohamed Abu-Farha; Jehad Abubaker; Ping Shi; Mor-Li Hartman; Mary Tavares; Milad Bitar; Hamad Ali; Hossein Arefanian; Sriraman Devarajan; Faisal Al-Refaei; Osama Alsmadi; Jaakko Tuomilehto; Fahd Al-Mulla
Journal:  Front Genet       Date:  2018-12-21       Impact factor: 4.599

6.  Value of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (Review).

Authors:  Dali Chen; Guowei Che
Journal:  Oncol Lett       Date:  2014-07-28       Impact factor: 2.967

7.  Meta-analysis reveals no correlation of caveolin-1 G14713A (G>A) gene polymorphism with increased cancer risk in Taiwanese population.

Authors:  Raju K Mandal; Mohammad Raish; Arshad Jawed; Mohd Wahid; Sajad A Dar; Mohtashim Lohani; Md Ekhlaque Ahmed Khan; Mohammed Y Areeshi; Naseem Akhter; Saif Khan; Shafiul Haque
Journal:  Int J Health Sci (Qassim)       Date:  2018 May-Jun

8.  The contribution of interleukin-8 genotypes and expression to nasopharyngeal cancer susceptibility in Taiwan.

Authors:  Chung-Yu Huang; Wen-Shin Chang; Chia-Wen Tsai; Te-Chun Hsia; Te-Chun Shen; Da-Tian Bau; Hao-Ai Shui
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.